Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $102.6 million.

  • Beam Therapeutics' Shares Outstanding (Weighted Average) rose 2446.39% to $102.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.6 million, marking a year-over-year increase of 2446.39%. This contributed to the annual value of $82.3 million for FY2024, which is 668.97% up from last year.
  • Latest data reveals that Beam Therapeutics reported Shares Outstanding (Weighted Average) of $102.6 million as of Q3 2025, which was up 2446.39% from $102.0 million recorded in Q2 2025.
  • Over the past 5 years, Beam Therapeutics' Shares Outstanding (Weighted Average) peaked at $102.6 million during Q3 2025, and registered a low of $60.2 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $76.3 million (2023), whereas its average is $76.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 9596.41% in 2021, then soared by 428.4% in 2024.
  • Quarter analysis of 5 years shows Beam Therapeutics' Shares Outstanding (Weighted Average) stood at $64.2 million in 2021, then grew by 9.01% to $70.0 million in 2022, then rose by 10.19% to $77.2 million in 2023, then rose by 6.69% to $82.3 million in 2024, then grew by 24.61% to $102.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $102.6 million for Q3 2025, versus $102.0 million for Q2 2025 and $88.0 million for Q1 2025.